Aurobindo Pharma

1,511.80

+0.90

(0.06%)

Market Cap

87,805.59 Cr

PE Ratio

25.16

Volume

7,07,047.00

Day High - Low

1,528.00 - 1,503.30

52W High-Low

1,525.90 - 1,016.10

compare with

Sun Pharmaceutical

1,878.20 (+0.81%)

Divis Laboratories

6,760.50 (-2.33%)

Torrent Pharmaceuticals

4,405.70 (+0.04%)

Cipla

1,432.10 (-0.32%)

Dr Reddys Laboratories

1,336.70 (+2.54%)

Key Fundamentals

Market Cap

87,805.59 Cr

EPS

59.81

PE Ratio

25.16

PB Ratio

2.50

Book Value

603.32

EBITDA

7,204.60

Dividend Yield

0.00 %

Industry

Healthcare

Sector

Pharmaceuticals

Return on Equity

10.67

Debt to Equity

0.24

Actual

Company News

View All News

Telangana HC Dismisses Aurobindo Promoters' Writ Petition

12 hrs ago

The Hon'ble High Court of Telangana dismissed a writ petition filed by Aurobindo Pharma promoters challenging a SEBI directive to deposit Rs. 6.53 crores in profits into IPEF.

CuraTeQ Biologics Gets CDSCO Nod for Bevacizumab Biosimilar22 hrs ago

Aurobindo Pharma's subsidiary CuraTeQ Biologics receives CDSCO marketing authorisation (Form CT 23) for Bevqolva®, its bevacizumab biosimilar.

Aurobindo Pharma: ₹45.37 Cr NSE Block Trade3 days ago

Aurobindo Pharma sees a block trade of ~3,03,451 shares on NSE at ₹1,495.10 per share, aggregating to ₹45.37 crores.

Peer Comparison Compare Peers on Screener

Competitors	LTP	Market Cap (₹ Cr.)	P/E Ratio	Revenue (₹ Cr.)	YoY Revenue Growth %	Net Profit (₹ Cr.)	YoY Profit Growth %	RSI
Sun Pharmaceutical	1,878.20	#1 4,50,643.09	40.81	#1 54,729.00	9.71	#1 10,980	16.07	64.89
Divis Laboratories	6,760.50	1,79,470.03	74.13	9,712.00	18.67	2,191	-1.02	64.06
Torrent Pharmaceuticals	4,405.70	1,49,108.91	65.68	11,539.40	6.99	1,911	26.24	58.52
Cipla	1,432.10	1,15,682.27	30.09	27,711.70	-2.46	3,783	-55.32	69.78
Dr Reddys Laboratories	1,336.70	1,11,566.73	26.16	33,593.30	-0.44	3,998	-86.05	59.87
Lupin	2,276.20	1,04,032.18	#1 19.28	27,487.50	19.98	5,345	#1 87.72	46.11
Mankind Pharma	2,503.00	1,03,325.11	56.36	12,744.20	20.90	2,007	7.65	73.37
Zydus Life Science	1,011.70	1,01,800.69	19.85	23,511.00	18.55	4,615	-0.32	69.47
Aurobindo Pharma	1,511.80	#9 87,805.59	#3 25.16	#3 32,345.60	#7 9.43	#6 3,484	#6 7.59	73.83
Laurus Labs	1,323.60	71,455.42	79.78	6,812.90	#1 21.03	884	21.18	80.26

Automatic Screeners on ScanX

Resistance 1 Breached

Growth Rate

Revenue Growth

9.43 %

Net Income Growth

9.93 %

Cash Flow Change

61.21 %

ROE

0.47 %

ROCE

10.77 %

EBITDA Margin (Avg.)

2.86 %

Corporate Action

Record Date	Corporate Action	Information	Announcement Day	LTP at Annoucement	LTP at Record Day
21 May 2026	Quarterly Result Announcement	NA	21 May 2026	1,485.90	1,511.30
23 Feb 2021	Dividend	₹ 1.50 /share	22 Feb 2021	959.45	858.10
30 Aug 2021	Dividend	₹ 1.50 /share	27 Aug 2021	856.50	709.95
18 Nov 2021	Dividend	₹ 1.50 /share	17 Nov 2021	690.05	666.55
21 Feb 2022	Dividend	₹ 1.50 /share	18 Feb 2022	650.05	656.80
07 Jun 2022	Dividend	₹ 4.50 /share	06 Jun 2022	529.70	522.50
17 Feb 2023	Dividend	₹ 3.00 /share	17 Feb 2023	445.05	479.90
20 Nov 2023	Dividend	₹ 3.00 /share	20 Nov 2023	936.40	1,007.35
20 Feb 2024	Dividend	₹ 1.50 /share	20 Feb 2024	1,002.00	1,040.50
05 Aug 2024	Buyback	1460	30 Jul 2024	1,479.35	1,443.65
29 Aug 2024	Annual General Meeting	NA	29 Aug 2024	1,404.35	1,564.20
09 Nov 2024	Quarterly Result Announcement	NA	09 Nov 2024	1,396.00	1,327.55
06 Feb 2025	Quarterly Result Announcement	NA	06 Feb 2025	1,156.60	1,191.75
26 May 2025	Quarterly Result Announcement	NA	26 May 2025	1,216.90	1,197.10
04 Aug 2025	Quarterly Result Announcement	NA	04 Aug 2025	1,101.40	1,079.80
08 Aug 2025	Dividend	₹ 4.00 /share	08 Aug 2025	1,079.80	1,069.60
10 Sept 2025	Annual General Meeting	NA	10 Sept 2025	1,052.90	1,044.05
05 Nov 2025	Quarterly Result Announcement	NA	05 Nov 2025	1,098.95	1,151.00
09 Feb 2026	Quarterly Result Announcement	NA	09 Feb 2026	1,150.55	1,191.00
23 Apr 2026	Buyback	1475	17 Apr 2026	1,421.30	1,420.90

Funding House	Current Holding %	1M Change	1M Change %	3M Change %
Bandhan Multi-Factor Fund Direct-Growth	3.55%	162141	3.34%	-0.21%
The Wealth Company Flexi Cap Fund Direct-Growth	0.98%	-19900	-1.42%	-1.31%
The Wealth Company Arbitrage Fund Direct-Growth	0.00%	-17050	-1.45%	-1.18%
TRUSTMF Multi Cap Fund Direct-Growth	0.53%	-16033	-0.61%	0.53%
Old Bridge Flexi Cap Fund Direct-Growth	3.15%	14000	0.79%	3.15%
ITI Business Cycle Fund Direct-Growth	1.17%	8694	1.17%	1.17%
Unifi Dynamic Asset Allocation Fund Direct-Growth	0.25%	-1650	-0.01%	-0.06%
Tata Nifty Midcap 150 Index Fund Direct-Growth	1.00%	1560	-0.05%	0.10%
Sundaram Multi-Factor Fund Direct-Growth	1.33%	-1437	-0.06%	0.20%
Edelweiss Nifty LargeMidcap250 Plus 8-13 Yr G-Sec 70:30 Index Fund Direct-Growth	0.35%	1075	0.35%	0.35%
Franklin India Multi-Factor Fund Direct-Growth	0.78%	992	-0.03%	0.08%
JioBlackRock Nifty Midcap 150 Index Fund Direct-Growth	0.99%	-750	-0.06%	0.09%
DSP Nifty Healthcare Index Fund Direct-Growth	3.84%	423	0.06%	0.44%
UTI Nifty500 Shariah Index Fund Direct-Growth	0.69%	408	-0.01%	0.09%
Zerodha Nifty LargeMidcap250 Plus 8-13 Yr G-Sec 70:30 Index Fund Direct-Growth	0.37%	398	0.37%	0.37%
Zerodha Nifty MidSmallcap400 50:50 Index Fund Direct-Growth	0.50%	284	0.50%	0.50%
JioBlackRock Sector Rotation Fund Direct-Growth	0.19%	260	0.00%	0.03%
Kotak Nifty Midcap 150 Index Fund Direct-Growth	1.00%	233	-0.05%	0.10%
Nippon India Nifty India Manufacturing Index Fund Direct-Growth	1.00%	127	-0.04%	0.12%
DSP Nifty Midcap 150 Index Fund Direct-Growth	0.99%	99	-0.05%	0.09%
Groww Nifty Midcap 150 Index Fund Direct-Growth	0.99%	37	-0.06%	0.09%
Motilal Oswal BSE 1000 Index Fund Direct-Growth	0.19%	32	-0.01%	0.03%
Navi Nifty MidSmallcap 400 Index Fund Direct-Growth	0.65%	21	-0.04%	0.05%
DSP Nifty 500 Index Fund Direct-Growth	0.20%	12	0.00%	0.03%
Mahindra Manulife Multi Cap Fund Direct-Growth	0.00%	0	0.00%	0.00%

Technical Indicators

RSI(14)

Neutral

73.83

ATR(14)

Less Volatile

34.57

STOCH(9,6)

Overbought

86.05

STOCH RSI(14)

Overbought

96.79

MACD(12,26)

Bullish

3.93

ADX(14)

Strong Trend

28.04

UO(9)

Bearish

44.12

ROC(12)

Uptrend And Accelerating

6.27

WillR(14)

Overbought

-10.06

About Aurobindo Pharma

Aurobindo Pharma Limited (APL) is an Indian pharmaceutical company founded in 1986. It manufactures and markets active pharmaceutical ingredients, generic formulations, and branded pharmaceuticals globally. APL specializes in various therapeutic areas including antibiotics, antiretrovirals, cardiovascular, central nervous system, and gastroenterological products. The company operates 24 manufacturing plants worldwide and has...more

Website

https://www.aurobindo.com

Chairperson NameM R Kumar

About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.
We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.
This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.
The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.
We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.
This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.
By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.
We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.

Part of Raise Financial Services

Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai - 400104

Aurobindo Pharma

Company News

Peer Comparison Compare Peers on Screener

Automatic Screeners on ScanX

Corporate Action

Mutual Fund Holdings

Technical Indicators

About Aurobindo Pharma